Top 25 Biotech Startups
--Sharing is Caring--

Top 25 Biotech Startups Companies Funded in Last 7 Days – Rs. 4409 Crores

We analyzed the Biotech Startup World and found that the following Startups got funded to an excess of 615 Million USD ~ equivalent of 4409 Crores Rupees in the last 7 days. Amazing Isn’t it? So Let’s find out which companies got funded and they are working on which idea. Analyze the data given below very carefully and do let us know what you find out in the comments section.

1. Name of Startup: Repare Therapeutics

  • Categories: Biotechnology, Health Care, Pharmaceutical
  • Headquarters Location: Saint Laurent, Quebec, Canada
  • Founded Year: 2016
  • Website: http://www.reparerx.com/

About Repare Therapeutics : Repare has developed and deployed a proprietary, high-throughput, genomic synthetic lethal screening platform that harnesses the precision and power of CRISPR/Cas9 genome editing, high-resolution protein crystallography and computational biology, and the unprecedented ability to exploit DNA Damage Repair (DDR) defects found across virtually all cancers.

  • Name of Founders: Agnel Sfeir, Daniel Durocher, Frank Sicheri
  • Date of Funding: 2019-09-04
  • Last Funding Amount: 82500000 USD
  • Last Funding Type: Series B
  • Top 5 Investors in Repare Therapeutics: BVF Partners, Celgene, Fonds de solidarité FTQ, OrbiMed, Versant Ventures

2.Name of Startup: immatics biotechnologies

  • Categories: Biotechnology, Manufacturing, Medical, Therapeutics
  • Headquarters Location: Tübingen, Baden-Wurttemberg, Germany
  • Founded Year: 2000
  • Website: http://www.immatics.net

About immatics biotechnologies : immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy. immatics has a good track record of success: They are optimistic that they have found a way to develop drugs against cancer that might one day help many cancer patients. The product candidates are designed to have less severe side effects than currently available treatment options. immatics has developed peptide-based active immunotherapy with unprecedented speed and efficiency, setting new standards for discovery and development in this area of oncology drug development. Our technology can also lead to the development of novel immunotherapies based on antibodies and T-cell receptors. immatics is currently working on the development of new substances for a number of specific cancer types. Their most advanced product is currently being developed in a phase 3 clinical trial for kidney cancer. Final results for this trial are expected in 2015. A second product targeting colorectal cancer has just completed a large phase 1/2 clinical trial and a third cancer vaccine has entered several phase 1 clinical trial in brain cancer. They also have active earlier programs in several other tumor types including gastric cancer, non-small-cell lung cancer and prostate cancer which are being developed in collaboration with our partner Roche.

  • Name of Founders: Hans Rammensee, Harpreet Singh
  • Date of Funding: 2019-09-05
  • Last Funding Amount: 75000000 USD
  • Last Funding Type: Venture – Series Unknown
  • Top 5 Investors in immatics biotechnologies: 3i Group, Amgen, Celgene, KfW, Swisscom Ventures

3.Name of Startup: PolyPid

  • Categories: Biopharma, Biotechnology, Pharmaceutical
  • Headquarters Location: Petah Tiqva, HaMerkaz, Israel
  • Founded Year: 2008
  • Website: http://www.polypid.com

About PolyPid : Founded in 2008 and located in Israel, PolyPid is a privately held, development stage company that has developed a platform technology for the healthcare industry that enables a controlled and prolonged release of any active pharmaceutical ingredients (API). PolyPid’s technology combines polymers and lipids, enabling small-and-large API entrapment in degradation and hydration protected environments, regardless of their chemical or physical characteristics. PolyPid allows the release of the API from the reservoir at pre-determined rates of up to several months, with a constant release rate (zero-order kinetics). The flexibility of this innovative technology enables local administration of compounds across numerous therapeutic classes for several applications. PolyPid Ltd. is owned by the founders, private investors and Xenia Venture Capital.

  • Name of Founders: Noam Emanuel
  • Date of Funding: 2019-09-04
  • Last Funding Amount: 50000000 USD
  • Last Funding Type: Series E
  • Top 5 Investors in PolyPid: Aurum Ventures, Chaim Hurvitz, Financière Saint James, GUIBOR, Shavit Capital

4.Name of Startup: Robocath

  • Categories: Biotechnology, Health Care, Medical, Robotics
  • Headquarters Location: Rouen, Haute-Normandie, France
  • Founded Year: 2009
  • Website: http://www.robocath.com/en/

About Robocath : Our mission is to protect physicians from occupational hazards and ensure an efficient treatment for patients. We develop an innovative device to remotely operate catheters addressing interventional practices such as cardiology and radiology (peripheral, neuro).

  • Name of Founders: Bruno Fournier, Philippe Bencteux
  • Date of Funding: 2019-09-03
  • Last Funding Amount: 5000000 EUR
  • Last Funding Type: Venture – Series Unknown
  • Top 5 Investors in Robocath: Caisse d’Epargne, GO CAPITAL, M Capital Partners, NCI, Supernova Invest

5.Name of Startup: StratifiCare, Inc.

  • Categories: Biotechnology, Health Care, Information Technology
  • Headquarters Location: Singapore, Central Region, Singapore
  • Founded Year: 2015
  • Website: http://www.stratificare.com

About StratifiCare, Inc.: StratifiCare™ was founded in Singapore in 2015 with the vision of revolutionizing how patients are managed and treated in the world. Due to the lack of advanced medical technology, physicians find it hard to provide individualized treatment for patients. This may result in less optimal clinical outcomes and usage of healthcare resources. By developing technologically advanced in vitro diagnostic solutions, we transform the way patients are managed through personalized care and create value for all. In 2019, it opened its US HQ to pursue its FDA approval and LATAM Market access for its flagship product StratifiDen. StratifiCare develops quality, innovative diagnostic tests to enable healthcare providers in delivering personalized curative therapies to every patient.

  • Name of Founders: Anthony Chua, Keith Mun Keat Chong, Mary Mah Lee Ng, Tiffany Fan Lin
  • Date of Funding: 2019-08-31
  • Last Funding Amount: 500000 USD
  • Last Funding Type: Seed
  • Top 5 Investors in StratifiCare, Inc.: Enterprise Singapore, Ministry of Health Singapore
See Also
Discovery Of Brand New RNA Molecules, Linked To Aging

6.Name of Startup: SkylineDx

  • Categories: Biotechnology, Health Care, Health Diagnostics
  • Headquarters Location: Rotterdam, Zuid-Holland, The Netherlands
  • Founded Year: 2005
  • Website: http://www.skylinedx.com/

About SkylineDx : SkylineDx is an emerging commercial-stage company focused on the development and commercialization of innovative gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. These tests are designed to accurately determine the type or status of the disease or to predict a patient’s response to a specific treatment.

  • Name of Founders: Dharminder Chahal
  • Date of Funding: 2019-09-02
  • Last Funding Amount: 20000000 EUR
  • Last Funding Type: Venture – Series Unknown
  • Top 5 Investors in SkylineDx: Van Herk Ventures

7.Name of Startup: AAVogen

  • Categories: Biotechnology, Health Care
  • Headquarters Location: Rockville, Maryland, United States
  • Founded Year: 2015
  • Website: http://www.aavogen.com

About AAVogen : AAVogen is a biotech startup that develops gene therapeutics for muscle-wasting diseases like muscular dystrophy and cancer cachexia. We make you stronger.

  • Name of Founders: Buel Rodgers
  • Date of Funding: 2019-09-01
  • Last Funding Amount: 225000 USD
  • Last Funding Type: Grant
  • Top 5 Investors in AAVogen: Kilpatrick Townsend, National Cancer Institute SBIR Development Center, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Washington Research Foundation.

8.Name of Startup: Perfectus Biomed

  • Categories: Biotechnology, Health Care, Medical Device
  • Headquarters Location: Chester, Cheshire, United Kingdom
  • Founded Year: 2012
  • Website: http://perfectusbiomed.com

About Perfectus Biomed : They are a microbiological services provider that provide our clients with a research-based approach to microbiological testing, whilst recognizing the client’s need for a rapid turnaround and a personalized service. We specialise in bespoke assays with a primary focus on biofilm testing. They appreciate that not all products are appropriate for standard testing assays and therefore we work closely with our clients to develop methods that are suitable for the testing of novel products. They offer an extremely customer-focused service that includes regular feedback, consultancy, method development and report writing. In addition, we produce conference abstracts and posters based on the data we produce.

  • Date of Funding: 2019-09-03
  • Last Funding Type: Grant
  • Top 5 Investors in Perfectus Biomed: National Biofilms Innovation Centre, The North West Fund, UK Innovation & Science Seed Fund

9.Name of Startup: PathoQuest

  • Categories: Biotechnology, SaaS, Therapeutics
  • Headquarters Location: Paris, Ile-de-France, France
  • Founded Year: 2010
  • Website: https://www.pathoquest.com/

About PathoQuest : PathoQuest SAS operates as a biotechnology company which identifies pathogens by means of High Throughput Sequencing (HTS). The company was founded in 2010 and is based in Paris, France.

  • Name of Founders: Luc Boblet, Marc Eloit
  • Date of Funding: 2019-09-05
  • Last Funding Amount: 8000000 EUR
  • Last Funding Type: Debt Financing
  • Top 5 Investors in PathoQuest: Charles River Laboratories International, Fraser Finance, Idinvest Partners, investiere | Verve Capital Partners, Kurma Partners

10.Name of Startup: Quantificare

About Quantificare :

  • Name of Founders:
  • Date of Funding: 2019-09-05
  • Last Funding Amount: 5000000 EUR
  • Last Funding Type: Series A
  • Top 5 Investors in Quantificare: LBO France

11.Name of Startup: Passage Bio

About Passage Bio: Passage Bio is a fully integrated gene therapy company with a mission to develop a portfolio of five life-transforming AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases. The company is based in Philadelphia, PA and has a research, collaboration and license agreement with the University of Pennsylvania and its Gene Therapy Program (GTP) as well as the Orphan Disease Center (ODC). Pursuant to the research collaboration, GTP conducts IND-enabling preclinical work, and Passage Bio is responsible for clinical development, regulatory, manufacturing and commercialization of all product candidates. The ODC is responsible for natural history studies, KOL engagement, and patient advocacy outreach.

  • Name of Founders: James Wilson
  • Date of Funding: 2019-09-04
  • Last Funding Amount: 110000000 USD
  • Last Funding Type: Series B
  • Top 5 Investors in Passage Bio: Frazier Healthcare Partners, Highline Capital Management, New Leaf Venture Partners, OrbiMed, Versant Ventures

12.Name of Startup: Novaremed AG

  • Categories: Biotechnology
  • Headquarters Location: Basel, Basel-Stadt, Switzerland
  • Founded Year: 2017
  • Website: http://www.novaremed.com/

About Novaremed AG :

  • Name of Founders:
  • Date of Funding: 2019-09-02
  • Last Funding Amount: 2600000 CHF
  • Last Funding Type: Venture – Series Unknown
  • Top 5 Investors in Novaremed AG:
See Also
UN Mosquito Sterilization Offers New Opportunity To Control Chikungunya, Dengue & Zika

13.Name of Startup: Gyroscope Therapeutics

  • Categories: Biotechnology, Therapeutics
  • Headquarters Location: Stevenage, Herefordshire, United Kingdom
  • Founded Year: 2017
  • Website: http://gyroscopetx.com/

About Gyroscope Therapeutics : Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of treatment delivery.

  • Name of Founders:
  • Date of Funding: 2019-09-03
  • Last Funding Amount: 57700000 USD
  • Last Funding Type: Series B
  • Top 5 Investors in Gyroscope Therapeutics: Cambridge Innovation Capital, Syncona Partners LLP

14.Name of Startup: In Diagnostics

About In Diagnostics: In Diagnostics is a Biotechnology company. They are developing next generation POC devices that rely on digital microchips to analyze biological samples.

  • Name of Founders:
  • Date of Funding: 2019-09-05
  • Last Funding Amount: 3000000 USD
  • Last Funding Type: Seed
  • Top 5 Investors in In Diagnostics:

15.Name of Startup: Novan

  • Categories: Biotechnology, Health Care, Medical
  • Headquarters Location: Raleigh, North Carolina, United States
  • Founded Year: 2008
  • Website: http://www.novantherapeutics.com

About Novan : Novan, Inc. develops products that tap the anti-bacterial properties of nitric oxide by encapsulating the compound in nano-particles that deliver therapeutic agents to desired body location. The company was incorporated in 2006 and is based in Research Triangle Park, North Carolina.

  • Name of Founders: Nathan Stasko
  • Date of Funding: 2019-09-06
  • Last Funding Amount: 25000000 USD
  • Last Funding Type: Post-IPO Equity
  • Top 5 Investors in Novan: Aspire Capital Partners LLC, Malin Corporation

16.Name of Startup: My Intelligent Machines

  • Categories: Artificial Intelligence, Bioinformatics, Biotechnology, Clinical Trials, CRM, Health Care, Information Technology, Life Science
  • Headquarters Location: Montréal, Quebec, Canada
  • Founded Year: 2016
  • Website: http://www.mims.ai/

About My Intelligent Machines : Competitive research carried out in the Pharma/Biotech industry, and in academia relies on massively produced omics data; the use of which requires bioinformatic expertise. Unfortunately, just a fraction of scientists have access to the expertise of bioinformaticians. Hiring a huge number of bioinformaticians is limited by the availability of qualified personnel and converting any scientist in bioinformaticians is unrealistic. They will address these critical problems by conceiving and implementing artificial intelligent systems, called MIMs (for My Intelligent Machines). MIMs will be accessible to non-specialists in bioinformatics and will also support the day-to-day work of bioinformatic groups.

  • Name of Founders: Abdoulaye Baniré Diallo, Mickaël Camus, Sarah Jenna
  • Date of Funding: 2019-09-05
  • Last Funding Amount: 2600000 USD
  • Last Funding Type: Seed
  • Top 5 Investors in My Intelligent Machines: Anges Quebec, FounderFuel, Innovacorp, MEDTEQ, Real Ventures

17.Name of Startup: Polaris Biology

  • Categories: Biopharma, Biotechnology, Health Care, Medical
  • Headquarters Location: Shanghai, Shanghai, China
  • Founded Year: 2016
  • Website: http://www.polarisbiology.com

About Polaris Biology : Polaris Biology is a medical technology company specializing in the development and clinical application of cell-level precision diagnostic technology, is dedicated to exploring and studying individual and dynamic changes in tumors at the cellular level, and using this information to support clinical tumor diagnosis and treatment.

  • Name of Founders:
  • Date of Funding: 2019-09-05
  • Last Funding Amount:
  • Last Funding Type: Series A
  • Top 5 Investors in Polaris Biology: Baidu Ventures, Emerging Technology Partners, Morningside Venture Capital, Volcanics Venture

18.Name of Startup: Nkarta Therapeutics

  • Categories: Biotechnology, Health Care
  • Headquarters Location: South San Francisco, California, United States
  • Founded Year: 2015
  • Website: https://www.nkartatx.com/

About Nkarta Therapeutics : Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited to a few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.

  • Name of Founders: Paul Hastings
  • Date of Funding: 2019-09-04
  • Last Funding Amount: 114000000 USD
  • Last Funding Type: Series B
  • Top 5 Investors in Nkarta Therapeutics: Life Sciences Partners, New Enterprise Associates, Novo Holdings, RA Capital Management, Samsara BioCapital

19.Name of Startup: MedAnnex Ltd

  • Categories: Biotechnology, Clinical Trials
  • Headquarters Location: Edinburgh, Edinburgh, City of, United Kingdom
  • Founded Year: 2009
  • Website: https://www.medannex.org/

About MedAnnex Ltd : Their patent-protected antibody approach has shown significant activity in experimental models of several serious autoimmune conditions. In most cases, autoimmune diseases are life-changing, with high medical, social and financial burdens. Patients often develop resistance to existing therapies, many of which have serious side-effects, so there is an urgent need for new treatments

  • Name of Founders:
  • Date of Funding: 2019-09-06
  • Last Funding Amount: 11000000 GBP
  • Last Funding Type: Series B
  • Top 5 Investors in MedAnnex Ltd: Morningside Group, Scottish Investment Bank.
See Also
Did You Know ? Our Brain Waves Follow Earthquake Like Patterns During Sleep!

20.Name of Startup: Sprout Pharmaceuticals

  • Categories: Biotechnology, Medical, Pharmaceutical
  • Headquarters Location: Raleigh, North Carolina, United States
  • Founded Year: 2011
  • Website: http://sproutpharma.com

About Sprout Pharmaceuticals : Sprout Pharmaceuticals develops products for the treatment of female sexual health. The company was incorporated in 2011 and is based in Raleigh, North Carolina.

  • Name of Founders: Cindy Eckert, Robert Whitehead
  • Date of Funding: 2019-09-04
  • Last Funding Amount: 20000000 USD
  • Last Funding Type: Venture – Series Unknown
  • Top 5 Investors in Sprout Pharmaceuticals:

21.Name of Startup: TreeFrog Therapeutics

  • Categories: Biotechnology, Therapeutics
  • Headquarters Location: Bordeaux, Aquitaine, France
  • Website: https://treefrog.fr/

About TreeFrog Therapeutics : TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies by overcoming current critical manufacturing issues. TreeFrog Therapeutics has developed C-Stem® : a proprietary technology platform that provides an end to end 3D scalable solution that will dramatically reduce treatment costs.

  • Name of Founders: Erwan Bezard, Jean-Luc Treillou, Kevin Alessandri, Laurent Cognet, Maxime Feyeux, Pierre Nassoy
  • Date of Funding: 2019-09-05
  • Last Funding Amount: 3300000 EUR
  • Last Funding Type: Grant
  • Top 5 Investors in TreeFrog Therapeutics: AQUITI Gestion, Bpifrance, European Commission, Galia Gestion, XAnge

22.Name of Startup: Collplant

  • Categories: 3D Printing, 3D Technology, Biotechnology, Health Care, Medical, Medical Device, Wellness
  • Headquarters Location: Ness Ziona, HaMerkaz, Israel
  • Founded Year: 1981
  • Website: http://www.collplant.com

About Collplant : CollPlant is regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also develops and commercializes tissue repair products for orthobiologics. The company’s products are based on the rhCollagen that is produced with CollPlant’s proprietary plant based genetic engineering technology. The rhCollagen BioInk is ideal for 3D bioprinting of tissues and organs, and the unique Vergenix line of rhCollagen products contains a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. CollPlant is based in Israel.

  • Name of Founders: Oded Shoseyov
  • Date of Funding: 2019-09-03
  • Last Funding Amount: 5500000 USD
  • Last Funding Type: Post-IPO Debt
  • Top 5 Investors in Collplant: Ami Sagi, Docor International Management, Meitav Investment House, Meitav Underwriting, Pontifax

23.Name of Startup: Strekin

  • Categories: Biotechnology, Pharmaceutical
  • Headquarters Location: Basel, Basel-Stadt, Switzerland
  • Founded Year: 2014
  • Website: https://www.strekin.com/

About Strekin : Strekin AG is a clinical-stage biopharmaceutical company headquartered in Basel, Switzerland. Strekin was founded in 2014 by Dr. Alexander Bausch, Prof. Dr. Daniel Bodmer, and Mr. Roger Meier.

  • Name of Founders: Alexander Bausch
  • Date of Funding: 2019-09-03
  • Last Funding Amount: 2820000 CHF
  • Last Funding Type: Series A
  • Top 5 Investors in Strekin:

24.Name of Startup: CONTINUUS Pharmaceuticals

  • Categories: Biotechnology, Medical, Pharmaceutical
  • Headquarters Location: Boston, Massachusetts, United States
  • Founded Year: 2012
  • Website: http://continuuspharma.com

About CONTINUUS Pharmaceuticals : CONTINUUS Pharmaceuticals works with pharmaceutical and generic companies under a Build-Own-Operate model. We design, build, and run the manufacturing process directly at the client site. This novel business model provides our clients with an exceptional, ”one-shop solution” for their entire development and manufacturing cycle. Our success is based on the establishment of long term partnerships with our pharmaceutical clients

  • Name of Founders: Bayan Takizawa, Salvatore Mascia
  • Date of Funding: 2019-09-05
  • Last Funding Amount: 5000000 USD
  • Last Funding Type: Series B
  • Top 5 Investors in CONTINUUS Pharmaceuticals: IMA Group, Mark Bamfoth, MassChallenge

25.Name of Startup: New Wave Foods

  • Categories: Advanced Materials, Biotechnology, Food and Beverage, Travel
  • Headquarters Location: San Francisco, California, United States
  • Founded Year: 2015
  • Website: http://www.newwavefoods.com/

About New Wave Foods : New Wave Foods is the leader in sustainable seafood. It is their mission to create food that is healthier for us and better for the environment while providing ingredients for outstanding culinary experiences.

  • Name of Founders: Dominique Barnes, Michelle Wolf
  • Date of Funding: 2019-09-05
  • Last Funding Type: Venture – Series Unknown
  • Top 5 Investors in New Wave Foods: IndieBio, New Crop Capital, Plug and Play, SOSV, Tyson Ventures

So how does it feel now? Isn’t that a slap on the face of those who say there is no scope in the BioTech Sector?


Keywords: top 25 biotech companies of 2019, biotech startups 2019, top biotech startups companies 2019, top biotechnology startups of 2019, biotechnology startups, top 25 biotech startups list 2019, top 25 biotechnology companies of 2019, top 25 biotechnology companies with funding, latest top 25 biotech startups list 2019, top 25 biotech companies startup of 2019, top 25 biotech startups that got funding 2019


Upload Your Resume' / CV to BioTecNika Talent Pool

Download This Notification
Shekhar Suman is the CEO & Managing Director of BioTecNika Info Labs Pvt Ltd, An avid reader who is passionate about Bio Sciences and has gifted us BioTecNika

2 COMMENTS

  1. How many of these are in India?
    There was always more opportunities outside India.
    And how this can help a fresher in India?

  2. I Miss. Saee Sanjay Chavan I am a student of Fy bsc biotechnology from pune maharashtra. I actually had an idea for arthritis disease to cure it . Please reply me.

Comments are closed.